Clinical Trials in Organ Transplantation in Children
8
0
0
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
25%
2 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C
Role: collaborator
B Cell Induction in Pediatric Lung Transplantation
Role: collaborator
Donor Alloantigen Reactive Tregs (darTregs) for Calcineurin Inhibitor (CNI) Reduction
Role: collaborator
Novel Mobile Device Application to Improve Adherence
Role: collaborator
Impact of Allo- and Autoantibodies on Chronic Cardiac Allograft Function
Role: collaborator
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children
Role: collaborator
Post-Traumatic Stress Symptoms (PTSS) in Transplant Recipients
Role: collaborator
Perceived Barriers to Patient Adherence After Pediatric Solid Organ Transplantation
Role: collaborator
All 8 trials loaded